The most common mistake I'm seeing in enterprise AI adoption right now: teams buying solutions for problems they haven't properly defined yet. The vendor pitch sounds good. The demo looks impressive. But six months later, nobody can measure the output.

What's actually working for us, and what I'd encourage others to pressure-test before any procurement sign-off.

We've confirmed the next executive dinner in the Technology Leaders – UK programme. 10 guests. Chatham House Rule. Private venue, London.

Topic: "AI as a competitive moat, separating real advantage from vendor noise." Invitations being extended this week to confirmed members. Check your inbox.

Great conversation at last month's dinner, following up here as promised. Anyone working at the intersection of AI and mid-market M&A, I'd value a proper conversation. Not a pitch, genuinely exploring how practitioners are thinking about AI-driven due diligence.

For anyone building a B2B health-tech brand from Series C to enterprise: the demand-gen playbook from consumer health does not translate. The buying committee is completely different. Here's what we changed, and why.